Back

Enhanced CRISPR/Cas-Based Immunoassay through Magnetic Proximity Extension and Detection

Shao, F.; Hu, J.; Zhang, P.; Akarapipad, P.; Park, J. S.; Lei, H.; Hsieh, K.; Wang, T.-H.

2024-09-10 primary care research
10.1101/2024.09.06.24313206
Show abstract

Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas-associated systems have recently emerged as a focal point for developing next-generation molecular diagnosis, particularly for nucleic acid detection. However, the detection of proteins is equally critical across diverse applications in biology, medicine, and the food industry, especially for diagnosing and prognosing diseases like cancer, Alzheimers and cardiovascular conditions. Despite recent efforts to adapt CRISPR/Cas systems for protein detection with immunoassays, these methods typically achieved sensitivity only in the femtomolar to picomolar range, underscoring the need for enhanced detection capabilities. To address this, we developed CRISPR-AMPED, an innovative CRISPR/Cas-based immunoassay enhanced by magnetic proximity extension and detection. This approach combines proximity extension assay (PEA) with magnetic beads that converts protein into DNA barcodes for quantification with effective washing steps to minimize non-specific binding and hybridization, therefore reducing background noise and increasing detection sensitivity. The resulting DNA barcodes are then detected through isothermal nucleic acid amplification testing (NAAT) using recombinase polymerase amplification (RPA) coupled with the CRISPR/Cas12a system, replacing the traditional PCR. This integration eliminates the need for thermocycling and bulky equipment, reduces amplification time, and provides simultaneous target and signal amplification, thereby significantly boosting detection sensitivity. CRISPR-AMPED achieves attomolar level sensitivity, surpassing ELISA by over three orders of magnitude and outperforming existing CRISPR/Cas-based detection systems. Additionally, our smartphone-based detection device demonstrates potential for point-of-care applications, and the digital format extends dynamic range and enhances quantitation precision. We believe CRISPR-AMPED represents a significant advancement in the field of protein detection.

Matching journals

1
Advanced Science
Wiley · based on 12 published papers
#1
331× avg
2
PLOS ONE
Public Library of Science (PLoS) · based on 1737 published papers
Top 47%
11.0%
3
Biosensors and Bioelectronics
Elsevier BV · based on 13 published papers
#1
163× avg
4
eLife
eLife Sciences Publications, Ltd · based on 262 published papers
Top 2%
6.7× avg
5
Microbiology Spectrum
American Society for Microbiology · based on 86 published papers
Top 0.4%
29× avg
6
Cell Reports Medicine
Elsevier BV · based on 49 published papers
Top 2%
13× avg
7
Communications Medicine
Springer Science and Business Media LLC · based on 63 published papers
Top 0.3%
14× avg
8
Nature Communications
Springer Science and Business Media LLC · based on 483 published papers
Top 28%
1.9%
9
Scientific Reports
Springer Science and Business Media LLC · based on 701 published papers
Top 70%
1.7%
10
Analytical Chemistry
American Chemical Society (ACS) · based on 15 published papers
Top 0.6%
33× avg
11
iScience
Elsevier BV · based on 74 published papers
Top 4%
5.9× avg
12
Science Translational Medicine
American Association for the Advancement of Science (AAAS) · based on 40 published papers
Top 3%
7.2× avg
13
The Lancet Infectious Diseases
Elsevier BV · based on 57 published papers
Top 5%
4.8× avg
14
Clinical Chemistry
Oxford University Press (OUP) · based on 14 published papers
Top 1%
13× avg
15
JAMA
American Medical Association (AMA) · based on 17 published papers
Top 0.9%
11× avg
16
Nutrients
MDPI AG · based on 43 published papers
Top 4%
3.4× avg
17
Journal of Alzheimer’s Disease
SAGE Publications · based on 23 published papers
Top 3%
5.3× avg
18
PLOS Neglected Tropical Diseases
Public Library of Science (PLoS) · based on 166 published papers
Top 12%
0.7%
19
Journal of Clinical Microbiology
American Society for Microbiology · based on 77 published papers
Top 5%
2.5× avg
20
Journal of Personalized Medicine
MDPI AG · based on 17 published papers
Top 2%
6.9× avg
21
EMBO Molecular Medicine
Springer Science and Business Media LLC · based on 15 published papers
Top 3%
7.4× avg